Subscribe To
MLSS / Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q4 2021 Results - Earnings Call Transcript
MLSS News
By Seeking Alpha
August 15, 2023
Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript
Milestone Scientific Inc. (NYSE:MLSS ) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants David Waldman - Investor Relat more_horizontal
By Seeking Alpha
June 15, 2023
Milestone Scientific: Buy For The $4 Billion Total Addressable Market
Milestone Scientific offers an innovative product line in the medical and dental segments, including a trademarked solution for Dentists to administer more_horizontal
By GlobeNewsWire
June 15, 2023
Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th
ROSELAND, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems tha more_horizontal
By Seeking Alpha
June 10, 2023
Milestone Scientific: Sales Could Start To Snowball
The shift to online sales in their dental business produced unexpectedly fast results with revenue and gross margin up sharply and more to come. Most more_horizontal
By Seeking Alpha
March 31, 2023
Milestone Scientific Inc. (MLSS) Q4 2022 Earnings Call Transcript
Milestone Scientific Inc. (NYSE:MLSS ) Q4 2022 Results Conference Call March 31, 2023 8:30 AM ET Company Participants David Waldman - Investor Relatio more_horizontal
By Seeking Alpha
April 19, 2022
Milestone Scientific Is Attractive Here
A new focus on their Dental business and the easing of the pandemic produced a strong recovery which has legs. The growth of the installed base of dev more_horizontal
By Proactive Investors
April 11, 2022
Milestone Scientific begins sales of its CompuFlo Epidural and CathCheck Verification System disposables to premier US hospital
Milestone Scientific Inc (NYSE:MLSS), the medtech group, revealed that it has begun selling its CompuFlo Epidural and CathCheck Verification System di more_horizontal
By Benzinga
April 4, 2022
Here's Why Maxim Reduced Price Target On Milestone Scientific
Maxim has lowered the price target on Milestone Scientific Inc (NYSE: MLSS) to $4 from $6 but maintained a Buy rating on the shares. Analyst An more_horizontal